Structural Heart Disease Treatment Devices Professional Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Replacement devices, Repair devices); End-user (Hospitals and clinics, ASCs) and Geography

Report Code: TIPRE00024859 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Structural heart disease refers to a problem with the tissues or valves of the heart. Many structural heart conditions could be witnessed since birth, but some may develop later in life because of wear and tear from infection. There are various kinds of structural heart diseases such as aortic valve stenosis, heart valve disease, left ventricular hypertrophy, myocarditis, mitral valve regurgitation, and many more. Various symptoms differ depending upon the condition and the patient. Although, general symptoms include shortness of breath, chest pain, high blood pressure, and mini-strokes.

MARKET SCOPE

The "Global Structural Heart Disease Treatment Devices Professional Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the structural heart disease treatment devices professional market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading structural heart disease treatment devices professional market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global structural heart disease treatment devices professional market is segmented into replacement devices and repair devices.
  •  On the basis of end-users, the market is bifurcated into hospitals and clinics, ASCs.

MARKET DYNAMICS
Drivers:

  •  Increase in the prevalence of structural heart diseases such as congenital heart defects, aortic stenosis, and heart valve disease.
  •  Rise in the number of innovative product launches.
  •  Technological advancement in structural heart disease treatment.
  •  Increase in the number of M&A activities.
  •  Strong clinical pipeline for heart valve devices.

Restraints:

  •  The high price associated with structural heart disease treatment procedures
  •  Lack of skilled personnel.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The structural heart disease treatment devices professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the structural heart disease treatment devices professional market in these regions.

IMPACT OF COVID-19 ON STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic outbreak had significantly slowed down the growth of the market due to worldwide lockdown. The treatment of various diseases was delayed as the appointments were postponed and canceled. All the focus was shifted towards COVID-19 patients, affecting the market growth. Moreover, the outbreak has also disrupted the supply chain, restricted trade, thereby affecting the business and caused less demand for the product impacting the market growth. However, the market will experience growth after the removal of restrictive measures and companies resuming their operations and adapting to the new normal.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the structural heart disease treatment devices professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from structural heart disease treatment devices professional market are anticipated to have lucrative growth opportunities in the future with the rising demand for structural heart disease treatment devices professional in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the structural heart disease treatment devices professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Abbott Laboratories
  •  Becton,Dickinson and Co.
  •  Braile Biomedica
  •  Boston Scientific Corp.
  •  CryoLife Inc.
  •  Edwards Lifesciences Corp.
  •  LivaNova Plc
  •  Lepu Medical Technology (Beijing) Co. Ltd.
  •  Medtronic Plc
  •  MicroPort Scientific Corp.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Structural Heart Disease Treatment Devices Professional Market - By Product
1.3.2 Structural Heart Disease Treatment Devices Professional Market - By End-user
1.3.3 Structural Heart Disease Treatment Devices Professional Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET - GLOBAL MARKET ANALYSIS
6.1. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL - GLOBAL MARKET OVERVIEW
6.2. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. REPLACEMENT DEVICES
7.3.1. Overview
7.3.2. Replacement devices Market Forecast and Analysis
7.4. REPAIR DEVICES
7.4.1. Overview
7.4.2. Repair devices Market Forecast and Analysis
8. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and clinics Market Forecast and Analysis
8.4. ASCS
8.4.1. Overview
8.4.2. ASCs Market Forecast and Analysis

9. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Structural Heart Disease Treatment Devices Professional Market Overview
9.1.2 North America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis
9.1.3 North America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Product
9.1.4 North America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By End-user
9.1.5 North America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Structural Heart Disease Treatment Devices Professional Market
9.1.5.1.1 Canada Structural Heart Disease Treatment Devices Professional Market by Product
9.1.5.1.2 Canada Structural Heart Disease Treatment Devices Professional Market by End-user
9.1.5.2 Mexico Structural Heart Disease Treatment Devices Professional Market
9.1.5.2.1 Mexico Structural Heart Disease Treatment Devices Professional Market by Product
9.1.5.2.2 Mexico Structural Heart Disease Treatment Devices Professional Market by End-user
9.1.5.3 US Structural Heart Disease Treatment Devices Professional Market
9.1.5.3.1 US Structural Heart Disease Treatment Devices Professional Market by Product
9.1.5.3.2 US Structural Heart Disease Treatment Devices Professional Market by End-user
9.2. EUROPE
9.2.1 Europe Structural Heart Disease Treatment Devices Professional Market Overview
9.2.2 Europe Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis
9.2.3 Europe Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Product
9.2.4 Europe Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By End-user
9.2.5 Europe Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Structural Heart Disease Treatment Devices Professional Market
9.2.5.1.1 Germany Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.1.2 Germany Structural Heart Disease Treatment Devices Professional Market by End-user
9.2.5.2 France Structural Heart Disease Treatment Devices Professional Market
9.2.5.2.1 France Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.2.2 France Structural Heart Disease Treatment Devices Professional Market by End-user
9.2.5.3 Italy Structural Heart Disease Treatment Devices Professional Market
9.2.5.3.1 Italy Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.3.2 Italy Structural Heart Disease Treatment Devices Professional Market by End-user
9.2.5.4 Spain Structural Heart Disease Treatment Devices Professional Market
9.2.5.4.1 Spain Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.4.2 Spain Structural Heart Disease Treatment Devices Professional Market by End-user
9.2.5.5 United Kingdom Structural Heart Disease Treatment Devices Professional Market
9.2.5.5.1 United Kingdom Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.5.2 United Kingdom Structural Heart Disease Treatment Devices Professional Market by End-user
9.2.5.6 Rest of Europe Structural Heart Disease Treatment Devices Professional Market
9.2.5.6.1 Rest of Europe Structural Heart Disease Treatment Devices Professional Market by Product
9.2.5.6.2 Rest of Europe Structural Heart Disease Treatment Devices Professional Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Structural Heart Disease Treatment Devices Professional Market Overview
9.3.2 Asia-Pacific Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis
9.3.3 Asia-Pacific Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Structural Heart Disease Treatment Devices Professional Market
9.3.5.1.1 Australia Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.1.2 Australia Structural Heart Disease Treatment Devices Professional Market by End-user
9.3.5.2 China Structural Heart Disease Treatment Devices Professional Market
9.3.5.2.1 China Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.2.2 China Structural Heart Disease Treatment Devices Professional Market by End-user
9.3.5.3 India Structural Heart Disease Treatment Devices Professional Market
9.3.5.3.1 India Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.3.2 India Structural Heart Disease Treatment Devices Professional Market by End-user
9.3.5.4 Japan Structural Heart Disease Treatment Devices Professional Market
9.3.5.4.1 Japan Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.4.2 Japan Structural Heart Disease Treatment Devices Professional Market by End-user
9.3.5.5 South Korea Structural Heart Disease Treatment Devices Professional Market
9.3.5.5.1 South Korea Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.5.2 South Korea Structural Heart Disease Treatment Devices Professional Market by End-user
9.3.5.6 Rest of Asia-Pacific Structural Heart Disease Treatment Devices Professional Market
9.3.5.6.1 Rest of Asia-Pacific Structural Heart Disease Treatment Devices Professional Market by Product
9.3.5.6.2 Rest of Asia-Pacific Structural Heart Disease Treatment Devices Professional Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Structural Heart Disease Treatment Devices Professional Market Overview
9.4.2 Middle East and Africa Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis
9.4.3 Middle East and Africa Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Structural Heart Disease Treatment Devices Professional Market
9.4.5.1.1 South Africa Structural Heart Disease Treatment Devices Professional Market by Product
9.4.5.1.2 South Africa Structural Heart Disease Treatment Devices Professional Market by End-user
9.4.5.2 Saudi Arabia Structural Heart Disease Treatment Devices Professional Market
9.4.5.2.1 Saudi Arabia Structural Heart Disease Treatment Devices Professional Market by Product
9.4.5.2.2 Saudi Arabia Structural Heart Disease Treatment Devices Professional Market by End-user
9.4.5.3 U.A.E Structural Heart Disease Treatment Devices Professional Market
9.4.5.3.1 U.A.E Structural Heart Disease Treatment Devices Professional Market by Product
9.4.5.3.2 U.A.E Structural Heart Disease Treatment Devices Professional Market by End-user
9.4.5.4 Rest of Middle East and Africa Structural Heart Disease Treatment Devices Professional Market
9.4.5.4.1 Rest of Middle East and Africa Structural Heart Disease Treatment Devices Professional Market by Product
9.4.5.4.2 Rest of Middle East and Africa Structural Heart Disease Treatment Devices Professional Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Structural Heart Disease Treatment Devices Professional Market Overview
9.5.2 South and Central America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis
9.5.3 South and Central America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Product
9.5.4 South and Central America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Structural Heart Disease Treatment Devices Professional Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Structural Heart Disease Treatment Devices Professional Market
9.5.5.1.1 Brazil Structural Heart Disease Treatment Devices Professional Market by Product
9.5.5.1.2 Brazil Structural Heart Disease Treatment Devices Professional Market by End-user
9.5.5.2 Argentina Structural Heart Disease Treatment Devices Professional Market
9.5.5.2.1 Argentina Structural Heart Disease Treatment Devices Professional Market by Product
9.5.5.2.2 Argentina Structural Heart Disease Treatment Devices Professional Market by End-user
9.5.5.3 Rest of South and Central America Structural Heart Disease Treatment Devices Professional Market
9.5.5.3.1 Rest of South and Central America Structural Heart Disease Treatment Devices Professional Market by Product
9.5.5.3.2 Rest of South and Central America Structural Heart Disease Treatment Devices Professional Market by End-user

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BECTON, DICKINSON AND CO.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRAILE BIOMEDICA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BOSTON SCIENTIFIC CORP.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CRYOLIFE INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EDWARDS LIFESCIENCES CORP.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. LIVANOVA PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDTRONIC PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MICROPORT SCIENTIFIC CORP.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Becton, Dickinson and Co.
3. Braile Biomedica
4. Boston Scientific Corp.
5. CryoLife Inc.
6. Edwards Lifesciences Corp.
7. LivaNova Plc
8. Lepu Medical Technology (Beijing) Co. Ltd.
9. Medtronic Plc
10. MicroPort Scientific Corp.
TIPRE00024859
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking